Chandler Park: Which patients would you not give EV-Pembro for 1st line metastatic bladder cancer?

Chandler Park shared on X:               .

“Which patients would you not give EV-Pembro for 1st line metastatic bladder cancer?

Dr. Guru Sonpavde and I discuss top line data of EV-302 and patients that we would be cautious to give this practice changing treatment.”

Proceed to the full video.

Source: Chandler Park/X

Chandler Park is an American physician, medical journalist, and clinical researcher. Park is a clinical professor at the University of Louisville School of Medicine, where he teaches biochemistry, physiology, hematology, and medical oncology. He also serves as an advisory dean, helping students transition into medical school and develop into physicians. 

Nationally recognized as an exceptional doctor, Park has participated in numerous cancer clinical trials and was honored as a distinguished fellow of the American College of Physicians (FACP) for his outstanding patient care and significant contributions to medical research.